Treatment too costly, work on it: SC to govt

New Delhi, March 8

The “exorbitant” cost of medical treatment in India today drew attention of the Supreme Court which told the government to “do something” as the people were unable to get treatment due to the “huge cost”.

The apex court’s remarks assume significance as the National Pharmaceutical Pricing Authority (NPPA) had recently said that non-scheduled drugs and diagnostic services constituted major components of charges billed to patients in four private hospitals in Delhi and National Capital Region (NCR) with margins as high as 1,192 per cent.

As per an analysis done by the NPPA, the margin on procurement price of drugs used in emergency cases for treatment of potentially life-threatening low blood pressure was 1,192 per cent.

The drug-pricing regulator had recently said that in case of Adrenor 2 ml injection with an MRP of Rs 189.95, the purchase price for the hospitals was Rs 14.70 but the patients were being charged Rs 5,318.60, including taxes.

A Bench comprising Justices Madan B Lokur, Kurian Joseph and Deepak Gupta asked the Centre whether any study has been conducted on the effects of air pollution on the health of people and the amounts spent on medical treatment of such ailments.

Additional Solicitor General ANS Nadkarni, appearing for the Centre, said a study on the impact of air pollution on the health of people has been conducted while some studies on the issue were going on. The Bench also asked the Centre to give publicity to various steps being taken to tackle the issue to make people aware as to what was happening. — PTI